1. Home
  2. PODD vs BCE Comparison

PODD vs BCE Comparison

Compare PODD & BCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PODD
  • BCE
  • Stock Information
  • Founded
  • PODD 2000
  • BCE 1880
  • Country
  • PODD United States
  • BCE Canada
  • Employees
  • PODD N/A
  • BCE N/A
  • Industry
  • PODD Medical/Dental Instruments
  • BCE
  • Sector
  • PODD Health Care
  • BCE
  • Exchange
  • PODD Nasdaq
  • BCE Nasdaq
  • Market Cap
  • PODD 22.1B
  • BCE 20.2B
  • IPO Year
  • PODD 2007
  • BCE N/A
  • Fundamental
  • Price
  • PODD $333.21
  • BCE $22.82
  • Analyst Decision
  • PODD Strong Buy
  • BCE Hold
  • Analyst Count
  • PODD 18
  • BCE 3
  • Target Price
  • PODD $354.17
  • BCE $29.50
  • AVG Volume (30 Days)
  • PODD 549.3K
  • BCE 2.9M
  • Earning Date
  • PODD 11-06-2025
  • BCE 11-06-2025
  • Dividend Yield
  • PODD N/A
  • BCE 5.53%
  • EPS Growth
  • PODD N/A
  • BCE 7324.86
  • EPS
  • PODD 3.45
  • BCE 4.80
  • Revenue
  • PODD $2,521,800,000.00
  • BCE $17,579,277,614.00
  • Revenue This Year
  • PODD $29.32
  • BCE $2.01
  • Revenue Next Year
  • PODD $18.37
  • BCE $3.06
  • P/E Ratio
  • PODD $96.40
  • BCE $4.76
  • Revenue Growth
  • PODD 27.11
  • BCE 0.11
  • 52 Week Low
  • PODD $230.05
  • BCE $20.28
  • 52 Week High
  • PODD $353.50
  • BCE $27.50
  • Technical
  • Relative Strength Index (RSI)
  • PODD 59.08
  • BCE 44.40
  • Support Level
  • PODD $311.51
  • BCE $22.71
  • Resistance Level
  • PODD $341.03
  • BCE $23.50
  • Average True Range (ATR)
  • PODD 11.79
  • BCE 0.48
  • MACD
  • PODD 1.86
  • BCE -0.00
  • Stochastic Oscillator
  • PODD 84.08
  • BCE 37.96

About PODD Insulet Corporation

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

About BCE BCE Inc.

BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to movie channels including HBO, Showtime, and Starz.

Share on Social Networks: